1-[4-(1,3-benzoxazol-2-yl)piperazin-1-yl]-2-(4-cyclopropylphenyl)ethanone;2-(4-cyclopropylphenyl)-1-[4-(3H-indol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(1-methylbenzimidazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(5-methyl-1,3-benzothiazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(5-methyl-1,3-benzoxazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(6-methyl-1,3-benzoxazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-([1,3]oxazolo[4,5-b]pyridin-2-yl)piperazin-1-yl]ethanone;N-[4-[2-[4-(4-fluoro-1,3-benzothiazol-2-yl)piperazin-1-yl]-2-oxoethyl]phenyl]methanesulfonamide;N-[4-[2-[4-(4-fluoro-6-methyl-1,3-benzothiazol-2-yl)piperazin-1-yl]-2-oxoethyl]phenyl]methanesulfonamide
C199H215F2N31O17S5 — CID 164971056
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-(1,3-benzoxazol-2-yl)piperazin-1-yl]-2-(4-cyclopropylphenyl)ethanone;2-(4-cyclopropylphenyl)-1-[4-(3H-indol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(1-methylbenzimidazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(5-methyl-1,3-benzothiazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(5-methyl-1,3-benzoxazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(6-methyl-1,3-benzoxazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-([1,3]oxazolo[4,5-b]pyridin-2-yl)piperazin-1-yl]ethanone;N-[4-[2-[4-(4-fluoro-1,3-benzothiazol-2-yl)piperazin-1-yl]-2-oxoethyl]phenyl]methanesulfonamide;N-[4-[2-[4-(4-fluoro-6-methyl-1,3-benzothiazol-2-yl)piperazin-1-yl]-2-oxoethyl]phenyl]methanesulfonamide
1-[4-(1,3-benzoxazol-2-yl)piperazin-1-yl]-2-(4-cyclopropylphenyl)ethanone;2-(4-cyclopropylphenyl)-1-[4-(3H-indol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(1-methylbenzimidazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(5-methyl-1,3-benzothiazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(5-methyl-1,3-benzoxazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(6-methyl-1,3-benzoxazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-([1,3]oxazolo[4,5-b]pyridin-2-yl)piperazin-1-yl]ethanone;N-[4-[2-[4-(4-fluoro-1,3-benzothiazol-2-yl)piperazin-1-yl]-2-oxoethyl]phenyl]methanesulfonamide;N-[4-[2-[4-(4-fluoro-6-methyl-1,3-benzothiazol-2-yl)piperazin-1-yl]-2-oxoethyl]phenyl]methanesulfonamide (PubChem CID 164971056) has the molecular formula C199H215F2N31O17S5 and a molecular weight of 3511.44 g/mol. Its IUPAC name is 1-[4-(1,3-benzoxazol-2-yl)piperazin-1-yl]-2-(4-cyclopropylphenyl)ethanone;2-(4-cyclopropylphenyl)-1-[4-(3H-indol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(1-methylbenzimidazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(5-methyl-1,3-benzothiazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(5-methyl-1,3-benzoxazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(6-methyl-1,3-benzoxazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-([1,3]oxazolo[4,5-b]pyridin-2-yl)piperazin-1-yl]ethanone;N-[4-[2-[4-(4-fluoro-1,3-benzothiazol-2-yl)piperazin-1-yl]-2-oxoethyl]phenyl]methanesulfonamide;N-[4-[2-[4-(4-fluoro-6-methyl-1,3-benzothiazol-2-yl)piperazin-1-yl]-2-oxoethyl]phenyl]methanesulfonamide.
Molecular Properties
| Compound Name | 1-[4-(1,3-benzoxazol-2-yl)piperazin-1-yl]-2-(4-cyclopropylphenyl)ethanone;2-(4-cyclopropylphenyl)-1-[4-(3H-indol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(1-methylbenzimidazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(5-methyl-1,3-benzothiazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(5-methyl-1,3-benzoxazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(6-methyl-1,3-benzoxazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-([1,3]oxazolo[4,5-b]pyridin-2-yl)piperazin-1-yl]ethanone;N-[4-[2-[4-(4-fluoro-1,3-benzothiazol-2-yl)piperazin-1-yl]-2-oxoethyl]phenyl]methanesulfonamide;N-[4-[2-[4-(4-fluoro-6-methyl-1,3-benzothiazol-2-yl)piperazin-1-yl]-2-oxoethyl]phenyl]methanesulfonamide |
|---|---|
| PubChem CID | 164971056 |
| Molecular Formula | C199H215F2N31O17S5 |
| Molecular Weight | 3511.44 g/mol |
| Exact Mass | 3508.55 |
| IUPAC Name | 1-[4-(1,3-benzoxazol-2-yl)piperazin-1-yl]-2-(4-cyclopropylphenyl)ethanone;2-(4-cyclopropylphenyl)-1-[4-(3H-indol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(1-methylbenzimidazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(5-methyl-1,3-benzothiazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(5-methyl-1,3-benzoxazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-(6-methyl-1,3-benzoxazol-2-yl)piperazin-1-yl]ethanone;2-(4-cyclopropylphenyl)-1-[4-([1,3]oxazolo[4,5-b]pyridin-2-yl)piperazin-1-yl]ethanone;N-[4-[2-[4-(4-fluoro-1,3-benzothiazol-2-yl)piperazin-1-yl]-2-oxoethyl]phenyl]methanesulfonamide;N-[4-[2-[4-(4-fluoro-6-methyl-1,3-benzothiazol-2-yl)piperazin-1-yl]-2-oxoethyl]phenyl]methanesulfonamide |
| SMILES | CS(=O)(=O)Nc1ccc(CC(=O)N2CCN(c3nc4c(F)cccc4s3)CC2)cc1.Cc1cc(F)c2nc(N3CCN(C(=O)Cc4ccc(NS(C)(=O)=O)cc4)CC3)sc2c1.Cc1ccc2nc(N3CCN(C(=O)Cc4ccc(C5CC5)cc4)CC3)oc2c1.Cc1ccc2oc(N3CCN(C(=O)Cc4ccc(C5CC5)cc4)CC3)nc2c1.Cc1ccc2sc(N3CCN(C(=O)Cc4ccc(C5CC5)cc4)CC3)nc2c1.Cn1c(N2CCN(C(=O)Cc3ccc(C4CC4)cc3)CC2)nc2ccccc21.O=C(Cc1ccc(C2CC2)cc1)N1CCN(C2=Nc3ccccc3C2)CC1.O=C(Cc1ccc(C2CC2)cc1)N1CCN(c2nc3ccccc3o2)CC1.O=C(Cc1ccc(C2CC2)cc1)N1CCN(c2nc3ncccc3o2)CC1 |
| InChI | InChI=1S/C23H26N4O.2C23H25N3O2.C23H25N3OS.C23H25N3O.C22H23N3O2.C21H23FN4O3S2.C21H22N4O2.C20H21FN4O3S2/c1-25-21-5-3-2-4-20(21)24-23(25)27-14-12-26(13-15-27)22(28)16-17-6-8-18(9-7-17)19-10-11-19;1-16-2-9-21-20(14-16)24-23(28-21)26-12-10-25(11-13-26)22(27)15-17-3-5-18(6-4-17)19-7-8-19;1-16-2-9-20-21(14-16)28-23(24-20)26-12-10-25(11-13-26)22(27)15-17-3-5-18(6-4-17)19-7-8-19;1-16-2-9-21-20(14-16)24-23(28-21)26-12-10-25(11-13-26)22(27)15-17-3-5-18(6-4-17)19-7-8-19;27-23(15-17-5-7-18(8-6-17)19-9-10-19)26-13-11-25(12-14-26)22-16-20-3-1-2-4-21(20)24-22;26-21(15-16-5-7-17(8-6-16)18-9-10-18)24-11-13-25(14-12-24)22-23-19-3-1-2-4-20(19)27-22;1-14-11-17(22)20-18(12-14)30-21(23-20)26-9-7-25(8-10-26)19(27)13-15-3-5-16(6-4-15)24-31(2,28)29;26-19(14-15-3-5-16(6-4-15)17-7-8-17)24-10-12-25(13-11-24)21-23-20-18(27-21)2-1-9-22-20;1-30(27,28)23-15-7-5-14(6-8-15)13-18(26)24-9-11-25(12-10-24)20-22-19-16(21)3-2-4-17(19)29-20/h2-9,19H,10-16H2,1H3;3*2-6,9,14,19H,7-8,10-13,15H2,1H3;1-8,19H,9-16H2;1-8,18H,9-15H2;3-6,11-12,24H,7-10,13H2,1-2H3;1-6,9,17H,7-8,10-14H2;2-8,23H,9-13H2,1H3 |
| InChIKey | DCWZBCWQZLYLSF-UHFFFAOYSA-N |
| XLogP | 31.36 |
| TPSA | 490.15 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 40 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 254 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3511.44 |
| LogP ≤ 5 | 31.36 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 40 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164971056 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.